<?xml version="1.0" encoding="UTF-8"?>
<p class="p">Various cell cycle checkpoints act as potential targets for cancer treatment [
 <xref rid="R10" ref-type="bibr" class="xref">10</xref>]. Several nutraceuticals prevent cancer cells from transitioning from the G1 to S phase. EOs and their constituents serve as effective anticancer substances by targeting cell cycle progression in cancer cells [
 <xref rid="R10" ref-type="bibr" class="xref">10</xref>]. In colorectal cancer cells, the maximal alteration in cancer cell cycle progression in the G2/M phase promoted by TA-1 was observed at 24 h. Volatile oils and their constituents serve as effective anticancer substances by targeting cell cycle progression in cancer cells [
 <xref rid="R10" ref-type="bibr" class="xref">10</xref>]. Thymol, a phenolic compound of Teucrium essential oil, induced cell cycle arrest at the G0/G1 phase [
 <xref rid="R39" ref-type="bibr" class="xref">39</xref>]. Gene products involved in cell proliferation were found here to be overexpressed in HCT116 cells. Hydrophobic and hydrophylic fractions decreased cell proliferation in human colon cancer cells through a decrease of Cyclin D1 and 
 <italic class="italic">p21</italic>.
</p>
